Login / Signup

Cost-utility analysis of a flash continuous glucose monitoring system in the management of people with type 2 diabetes mellitus on basal insulin therapy-An Italian healthcare system perspective.

Stefano Del PratoFrancesco GiorginoKirk SzafranskiYeesha Poon
Published in: Diabetes, obesity & metabolism (2024)
From an Italian healthcare system perspective, flash CGM is cost effective compared with SMBG for people living with T2DM on basal insulin.
Keyphrases
  • type diabetes
  • glycemic control
  • weight loss
  • mesenchymal stem cells
  • cell therapy